By proceeding, you agree to our Terms of Use and Privacy Policy.
Brett Jesse Greene is the Chief Innovation Officer at Cybin, Inc. He was the Founder, President and Chief Strategy Officer at the Adelia Therapeutics, Inc. which was acquired by Cybin, Inc. that works in the field of psychedelic drug discovery.
Talks About #Innovation
Preferred Locations #NorthAmerica
Over the last half-decade, we have witnessed game-changing developments within the cannabinoid field, driving it into a new era of rigorous research, promising clinical trials and multimillion-dollar deals.
